Isocitrate Dehydrogenase Gene Mutations in Cholangiocarcinoma

被引:0
|
作者
Wachsmann, Megan [1 ]
Pinho, Daniella [1 ]
Ram, Rosalyn [1 ]
Hammer, Suntrea T. G. [1 ]
Oliver, Dwight [1 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:452A / 453A
页数:2
相关论文
共 50 条
  • [1] Isocitrate Dehydrogenase Gene Mutations in Cholangiocarcinoma
    Wachsmann, Megan
    Pinho, Daniella
    Ram, Rosalyn
    Hammer, Suntrea T. G.
    Oliver, Dwight
    LABORATORY INVESTIGATION, 2017, 97 : 452A - 453A
  • [2] Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
    Kipp, Benjamin R.
    Voss, Jesse S.
    Kerr, Sarah E.
    Fritcher, Emily G. Barr
    Graham, Rondell P.
    Zhang, Lizhi
    Highsmith, W. Edward
    Zhang, Jun
    Roberts, Lewis R.
    Gores, Gregory J.
    Halling, Kevin C.
    HUMAN PATHOLOGY, 2012, 43 (10) : 1552 - 1558
  • [3] Mutations of isocitrate dehydrogenase 1 and 2 in intrahepatic cholangiocarcinoma
    Grassian, Alexandra R.
    Pagliarini, Raymond
    Chiang, Derek Y.
    CURRENT OPINION IN GASTROENTEROLOGY, 2014, 30 (03) : 295 - 302
  • [4] Isocitrate Dehydrogenase Mutations in Cholangiocarcinoma: Still a Long Road Ahead
    Nichetti, Federico
    Niger, Monica
    JCO PRECISION ONCOLOGY, 2022, 6
  • [5] Comparative Study of Isocitrate Dehydrogenase 1 Mutations in Intraheptatic Cholangiocarcinoma by Immunohistochemistry and Pyrosequencing
    Lo, Amy A.
    Costa, Helio A.
    Zehnder, Jim
    Dittman, David
    Rao, Sam
    Yang, Guang-Yu
    Beaubier, Nike
    LABORATORY INVESTIGATION, 2016, 96 : 443A - 444A
  • [6] Comparative Study of Isocitrate Dehydrogenase 1 Mutations in Intraheptatic Cholangiocarcinoma by Immunohistochemistry and Pyrosequencing
    Lo, Amy A.
    Costa, Helio A.
    Zehnder, Jim
    Dittman, David
    Rao, Sam
    Yang, Guang-Yu
    Beaubier, Nike
    MODERN PATHOLOGY, 2016, 29 : 443A - 444A
  • [7] Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma
    Saha, Supriya K.
    Gordan, John D.
    Kleinstiver, Benjamin P.
    Vu, Phuong
    Najem, Mortada S.
    Yeo, Jia-Chi
    Shi, Lei
    Kato, Yasutaka
    Levin, Rebecca S.
    Webber, James T.
    Damon, Leah J.
    Egan, Regina K.
    Greninger, Patricia
    McDermott, Ultan
    Garnett, Mathew J.
    Jenkins, Roger L.
    Rieger-Christ, Kimberly M.
    Sullivan, Travis B.
    Hezel, Aram F.
    Liss, Andrew S.
    Mizukami, Yusuke
    Goyal, Lipika
    Ferrone, Cristina R.
    Zhu, Andrew X.
    Joung, J. Keith
    Shokat, Kevan M.
    Benes, Cyril H.
    Bardeesy, Nabeel
    CANCER DISCOVERY, 2016, 6 (07) : 727 - 739
  • [8] Frequency and prognostic significance of isocitrate dehydrogenase 1 mutations in cholangiocarcinoma: a systematic literature review
    Boscoe, Audra N.
    Rolland, Catherine
    Kelley, Robin Kate
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (04) : 751 - +
  • [9] Radiomic model for predicting mutations in the isocitrate dehydrogenase gene in glioblastomas
    Hsieh, Kevin Li-Chun
    Chen, Cheng-Yu
    Lo, Chung-Ming
    ONCOTARGET, 2017, 8 (28) : 45888 - 45897
  • [10] Isocitrate dehydrogenase mutations in gliomas
    Waitkus, Matthew S.
    Diplas, Bill H.
    Yan, Hai
    NEURO-ONCOLOGY, 2016, 18 (01) : 16 - 26